DELTAZINE 1:100,000 articaine hydrochloride and adrenaline (epinephrine) 1.7mL solution for injection Australien - engelska - Department of Health (Therapeutic Goods Administration)

deltazine 1:100,000 articaine hydrochloride and adrenaline (epinephrine) 1.7ml solution for injection

specialites septodont pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 18.2 microgram/ml (equivalent: adrenaline (epinephrine), qty microgram/ml); articaine hydrochloride, quantity: 40 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; sodium metabisulfite; water for injections; sodium chloride - for local or regional anaesthesia for both simple and complex dental procedures in adult, adolescents and children 4 years of age and older. deltazine 1:100,000 is indicated only for dental procedures.

BERINERT IV human C1 esterase inhibitor 1500 IU powder for injection vial with diluent vial Australien - engelska - Department of Health (Therapeutic Goods Administration)

berinert iv human c1 esterase inhibitor 1500 iu powder for injection vial with diluent vial

csl behring australia pty ltd - water for injections, quantity: 3 ml - injection, diluent for - excipient ingredients: - berinert iv is indicated for the treatment of acute attacks in patients with hereditary angioedema (hae).

BERINERT IV human C1 esterase inhibitor 500 IU powder for injection vial with diluent vial Australien - engelska - Department of Health (Therapeutic Goods Administration)

berinert iv human c1 esterase inhibitor 500 iu powder for injection vial with diluent vial

csl behring australia pty ltd - water for injections, quantity: 10 ml - injection, diluent for - excipient ingredients: - berinert iv is indicated for the treatment of acute attacks in patients with hereditary angioedema (hae).

METARAMINOL GH PHARMA metaraminol (as tartrate) 10mg/1mL injection ampoule Australien - engelska - Department of Health (Therapeutic Goods Administration)

metaraminol gh pharma metaraminol (as tartrate) 10mg/1ml injection ampoule

global harvest pharmaceuticals pty ltd - metaraminol tartrate, quantity: 19 mg (equivalent: metaraminol, qty 10 mg) - injection, solution - excipient ingredients: sodium metabisulfite; sodium chloride; water for injections - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

METARAMINOL GH PHARMA metaraminol (as tartrate) 5 mg/10 mL solution for injection, vial Australien - engelska - Department of Health (Therapeutic Goods Administration)

metaraminol gh pharma metaraminol (as tartrate) 5 mg/10 ml solution for injection, vial

global harvest pharmaceuticals pty ltd - metaraminol tartrate, quantity: 9.5 mg (equivalent: metaraminol, qty 5 mg) - injection, solution - excipient ingredients: sodium metabisulfite; sodium chloride; water for injections - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

METARAMINOL GH PHARMA metaraminol (as tartrate) 3 mg/6 mL solution for injection, vial Australien - engelska - Department of Health (Therapeutic Goods Administration)

metaraminol gh pharma metaraminol (as tartrate) 3 mg/6 ml solution for injection, vial

global harvest pharmaceuticals pty ltd - metaraminol tartrate, quantity: 5.7 mg (equivalent: metaraminol, qty 3 mg) - injection, solution - excipient ingredients: sodium metabisulfite; sodium chloride; water for injections - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia

OXYCODONE-HAMELN oxycodone hydrochloride 50 mg/1 mL injection solution ampoule Australien - engelska - Department of Health (Therapeutic Goods Administration)

oxycodone-hameln oxycodone hydrochloride 50 mg/1 ml injection solution ampoule

hameln pharma pty ltd - oxycodone hydrochloride, quantity: 50 mg - injection, solution - excipient ingredients: citric acid monohydrate; hydrochloric acid; sodium citrate dihydrate; water for injections; sodium hydroxide; sodium chloride - oxycodone-hameln solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE-HAMELN oxycodone hydrochloride 10 mg/1 mL injection solution ampoule Australien - engelska - Department of Health (Therapeutic Goods Administration)

oxycodone-hameln oxycodone hydrochloride 10 mg/1 ml injection solution ampoule

hameln pharma pty ltd - oxycodone hydrochloride, quantity: 10 mg - injection, solution - excipient ingredients: sodium citrate dihydrate; sodium hydroxide; sodium chloride; hydrochloric acid; water for injections; citric acid monohydrate - oxycodone-hameln solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE-HAMELN oxycodone hydrochloride 20 mg/2 mL injection solution ampoule Australien - engelska - Department of Health (Therapeutic Goods Administration)

oxycodone-hameln oxycodone hydrochloride 20 mg/2 ml injection solution ampoule

hameln pharma pty ltd - oxycodone hydrochloride, quantity: 20 mg - injection, solution - excipient ingredients: citric acid monohydrate; sodium chloride; hydrochloric acid; sodium citrate dihydrate; water for injections; sodium hydroxide - oxycodone-hameln solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

EPHEDRINE HYDROCHLORIDE SXP ephedrine hydrochloride  30mg / mL solution for injection ampoule Australien - engelska - Department of Health (Therapeutic Goods Administration)

ephedrine hydrochloride sxp ephedrine hydrochloride 30mg / ml solution for injection ampoule

southern cross pharma pty ltd - ephedrine hydrochloride, quantity: 30 mg - injection, solution - excipient ingredients: water for injections - ephedrine hydrochloride injection is indicated in the treatment of hypotension secondary to spinal anaesthesia.